3 ms·

In theory then a bunch of pharma startups that have nailed their marketing costs should then flood the market with cheap new stuff. Why haven't they?

• peteradio 3y ago
  What incentive is there to do that? Is there anything preventing them from being gobbled up by current giants?
  • lxm 3y ago
    Being gobbled up at a premium is a reasonable exit strategy.
    • peteradio 3y ago
      Well yea, but OP wondered where are these cheap drugs.